BCTG Avocats’ cross-functional healthcare and life sciences practice encompasses regulation, competition, distribution and intellectual property matters across the pharmaceutical, medtech, biotech and OTC product laboratory sectors. François Dauba showcases expertise in drafting and negotiating commercial contracts for pharmaceutical clients, while Hugues Villey-Desmeserets regularly represents clients before professional associations and criminal courts. Gaëlle Bloret-Pucci is an experienced IP litigator, and Séverin Kullmann advises domestic and international clients on private equity transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team suggest innovative approaches, and are both serious and professional.’
- ‘The team demonstrate good knowledge of the healthcare and retail sectors, a pragmatic approach and responsiveness.’
- ‘The team are very responsive. They listen to the client's needs and constraints, are proactive, and do not hesitate to make suggestions.’
- ‘A closely-knit, dynamic and responsive team, adapting to cutting-edge technologies and surrounding itself with the necessary experts.’
- ‘I appreciate and commend the availability and responsiveness of the team.’
- ‘A competent, diligent, proactive, and very pleasant team.'
Key clients
- Genosafe
- NHCO Nutrition
- Zentiva
- PLG
- Pharmonweb
- Pharmedisound
- Pharma LCA Consortium
- Infecto Pharma
- Sandoz
- Uriage
- EssilorLuxottica
- Ceva
Work highlights
Advised the Pharma LCA Consortium to ensure that its activities comply with the competition rules applicable to standardization agreements and sustainability agreements, and that the relationship between the consortium and public authorities or other organizations developing competing standards complies with competition rules.
Advised Nozin on the launch of a new product on the French market, manufactured and distributed in the USA.
Advised several generic and biosimilar drug laboratories on overhauling their communications policy and defining their commercial policy in anticipation of expected regulatory changes.
Practice head
François Dauba; Hugues Villey-Desmeserets; Gaëlle Bloret-Pucci; Caroline Goupil; Séverin Kullmann; Aymeric Malphettes; Sabine de Paillerets; Cyprien Dufournier